NSE: ENTERO
ENTERO HEALTHCARE SOLU L
Price history
+49.24% over 3M
Performance
52-week range
Position in day range
ENTERO stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹1,458.69
RSI (14)
41
Neutral momentum
Volatility (ATR)
5.05%
High
Close streak
3d down
Volume vs 20d avg
0.51x
From 52W high
-9.91%
Up from 52W low
+83.24%
Green days (20)
11/20
Monthly seasonality
Average monthly move for ENTERO across the available price history.
Key statistics
Open
1,669.9
Day high
1,737.8
Day low
1,669.9
Prev close
1,729.8
Volume
2.45 L
Avg vol (20d)
4.80 L
52W high
1,920
52W low
944
ENTERO quarterly results
All ENTERO results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹1,940 cr
+38.2% YoY
Net profit
₹38.16 cr
+37.3% YoY
Operating profit
₹84.68 cr
+105.5% YoY
EPS
₹8.77
+37.2% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹1,940 cr | ₹84.68 cr | ₹38.16 cr | 4.4% | 2.0% | ₹8.77 | +37.3% | +36.2% |
| Q4 FY262026-03-31 | ₹1,910 cr | ₹71.25 cr | ₹28.01 cr | 3.7% | 1.5% | ₹6.44 | — | +1.4% |
| Q3 FY262025-12-31 | ₹1,707 cr | ₹57.98 cr | ₹27.63 cr | 3.4% | 1.6% | ₹6.35 | — | -12.6% |
| Q2 FY262025-09-30 | ₹1,571 cr | ₹52.23 cr | ₹31.6 cr | 3.3% | 2.0% | ₹7.26 | — | +13.7% |
| Q1 FY262025-06-30 | ₹1,404 cr | ₹41.2 cr | ₹27.8 cr | 2.9% | 2.0% | ₹6.39 | — | — |
| TTM (last 4 quarters) | ₹7,128 cr | ₹266 cr | ₹125 cr | 3.7% | 1.8% | ₹28.82 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Entero Healthcare Solu Jumps 3.65% to ₹1,729.80 After Block Deal Update — Levels, Volumes and the Follow-Up to Track
Entero Healthcare Solu (ENTERO) trades at ₹1,729.80, +63.20 (+3.65%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Block Deal Story Puts Entero Healthcare Solu in Play: Share Price Jumps 3.65% to ₹1,729.80, and Here Is the Arithmetic
Entero Healthcare Solu (ENTERO) trades at ₹1,729.80, +63.20 (+3.65%) as the block-deal story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Latest market news
Manipal Health Enterpri Opens Gap-Down at ₹725.00 After IPO Update — Levels, Volumes and the Follow-Up to Track
Manipal Health Enterpri (MANIPALHOS) trades at ₹738.95, +17.40 (+2.35%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Breaking: Ethereum Rallies 5.05% to $2,641.48 (19 September 2026)
Ethereum (ETH) is up 5.05% at $2,641.48 as of 01:15 am IST, dragging the wider crypto board with it.
Morning Market Buzz, 19 September 2026: IPOs Tops the Coverage Ahead of Industry And Sectors and Technology And IT
The most-covered market themes in the morning session on 19 September 2026 — IPOs, industry and sectors, technology and IT — with our live numbers for each and links to the publishers running the story.
Rategain Travel Techn Share Price Opens Gap-Up at ₹865.80: What Is Driving RATEGAIN Today, and the Levels That Matter
Rategain Travel Techn (RATEGAIN) trades at ₹852.00, -13.45 (-1.58%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
G R Infraprojects Sees 2.2x Volume Spike — Should Investors Read This as a Trend or a One-Day Move?
G R Infraprojects (GRINFRA) trades at ₹823.40, -5.65 (-0.69%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
HDIL in Focus: Housing Dev & Infra Share Price Slips to 52-Week Low on Rising Newsflow
Housing Dev & Infra (HDIL) trades at ₹1.45, -0.02 (-1.38%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.

